JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for FSL Archives


FSL Archives

FSL Archives


FSL@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Monospaced Font

LISTSERV Archives

LISTSERV Archives

FSL Home

FSL Home

FSL  April 2011

FSL April 2011

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: VBM -Contrast matrix design for clinical measures

From:

"Rajagopalan, Venkateswaran" <[log in to unmask]>

Reply-To:

FSL - FMRIB's Software Library <[log in to unmask]>

Date:

Fri, 29 Apr 2011 09:20:24 -0400

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (261 lines)

Dear Steve,
 
Thanks
 
No - I was referring to what you called "diagnostic criteria" as being ordinal (taking on several indicator values).

Yes you are right I have ordinal score ranging from 1 to 4 from your previous response to this " however if you have several different diagnostic criteria, and don't want to assume a linear relationship between the different indicator values, you should have a separate EV for each different value, and then do contrasts between these."
 so in this case is it correct to have the following design EV1 (score1) EV2(score2) EV3(score3) EV4 (score4) so in this case is there a way to separate the controls from my "GM_mod_merg_s3" file and retain the same order of my patients data. Also I am interested in knowing whether there is a correlation in diagnostic criteria with the GM volume changes in each patient group so is it correct to use the following design EV1 (group1) EV2(group2) EV3(group3) EV4 (group4) EV5 (diagnostic criteria)

You can't - you would have to use a different model, with a separate EV for each group for each clinical measure.

so in this case my design goes like this EV1 (group1) EV2(group2) EV3(group3) EV4 (group4) EV5 (diagnostic criteria) right?

Thanks very much

Venkat


 

________________________________

From: FSL - FMRIB's Software Library on behalf of Stephen Smith
Sent: Fri 4/29/2011 1:48 AM
To: [log in to unmask]
Subject: Re: [FSL] VBM -Contrast matrix design for clinical measures


Hi

On 28 Apr 2011, at 14:41, Rajagopalan, Venkateswaran wrote:


All the above looks fine I think - however if you have several different diagnostic criteria, and don't want to assume a linear relationship between the different indicator values, you should have a separate EV for each different value, and then do contrasts between these.



I don't have several different diagnostic criteria but several clinical measures namely duration of disease, then a diagnostic criteria to tell about the disease stage and disease progression rate to tell how fast disease progressess.



No - I was referring to what you called "diagnostic criteria" as being ordinal (taking on several indicator values).


So I chose a separate EV for the above 3 different clinical measures

My first question is are the changes seen in GM volume in patients ( all patient groups considered as single patient group here originally there are 4 different patient groups based on their clinical phenotype) correlate with the above clinical measures.

So for this is the following design correct

0 0 0 0 0 1 0 0 ----for correalting clinical measure of disease duartion with GM volume changes (Where Ev1 is control group, EV2-EV5 patient groups, EV6 -disease duration, EV7-diagnostic criteria and EV8 disease progression rate)

0 0 0 0 0 0 1 0 ----for correalting clinical measure of diagnostic criteria with GM volume changes

0 0 0 0 0 0 0 1----for correalting clinical measure of disease progression rate with GM volume changes

If I see a correlation between GM volume changes with any of the clinical measures (in my above step) then as a second step I want to do a correlation of the clinical measures with the 4 patient groups separately so in that case how can I set the contrast matrix.



You can't - you would have to use a different model, with a separate EV for each group for each clinical measure.

Cheers.




Thanks

Regards
Venkat


________________________________

From: FSL - FMRIB's Software Library on behalf of Stephen Smith
Sent: Thu 4/28/2011 12:59 AM
To: [log in to unmask]
Subject: Re: [FSL] VBM -Contrast matrix design for clinical measures


Hi,

On 27 Apr 2011, at 22:21, Rajagopalan, Venkateswaran wrote:


Hi All,

I did FSL-VBM analysis on my T1 w images. I have a control group and 4 patient groups. I also have clinical measures namely disease duration, diagnostic criteria and disease progression rate. Of these clinical measures diagnostic criteria is ordinal (for instance 1 for possible, 2 for probable etc). I read archives related to GLM design and understood how to prepare my design matrix etc. I just would like to make sure that my design matrix is correct for the following investigation. I am interested in looking for any GM difference between control and patients and also interested in correlation of clinical measures with changes in GM volume in patients.

My EVs are EV1 (control), EV2 (patient group 1),....EV5(patient group4), EV6(demeaned disease duration values in all patients and zero for controls), EV7( demeaned diagnostic criteria) and Ev8 (demeaned disease progression rate). So my contrast matrix I as follows

Control >patient group1 1 -1 0 0 0 0 0 0

Control > patient group2 1 0 -1 0 0 0 0 0

.

.

.

Similarly I designed it for control vs other patient groups but for clinical measures correlation with patient groups GM changes I am not clear how to design the contrast matrix is it like this

Clinical measure disease duration changes with all patients (in the sense considering the 4 different groups as a single group)

0 0 0 0 0 1 0 0

Then For Clinical measure of diagnostic criteria

0 0 0 0 0 0 1 0

All the above looks fine I think - however if you have several different diagnostic criteria, and don't want to assume a linear relationship between the different indicator values, you should have a separate EV for each different value, and then do contrasts between these.


And demeaned disease progression rate

0 0 0 0 0 0 0 1

If I want to compare each and every patient group with clinical measure then is the following a correct way to design the matrix

disease duration

0 1 1 1 1 -1 0 0

I don't think this (or the below) makes sense - you are contrasting the mean patient level with the duration correlation - what question did you intend to ask?

Cheers



diagnostic criteria

0 1 1 1 1 0 -1 0

demeaned disease progression rate

0 1 1 1 1 0 0 -1

Thanks

Venkat












===================================

Please consider the environment before printing this e-mail



Cleveland Clinic is ranked one of the top hospitals
in America by U.S.News & World Report (2010).
Visit us online at http://www.clevelandclinic.org <http://www.clevelandclinic.org/> <http://www.clevelandclinic.org/> for
a complete listing of our services, staff and
locations.


Confidentiality Note: This message is intended for use
only by the individual or entity to which it is addressed
and may contain information that is privileged,
confidential, and exempt from disclosure under applicable
law. If the reader of this message is not the intended
recipient or the employee or agent responsible for
delivering the message to the intended recipient, you are
hereby notified that any dissemination, distribution or
copying of this communication is strictly prohibited. If
you have received this communication in error, please
contact the sender immediately and destroy the material in
its entirety, whether electronic or hard copy. Thank you.




---------------------------------------------------------------------------
Stephen M. Smith, Professor of Biomedical Engineering
Associate Director, Oxford University FMRIB Centre

FMRIB, JR Hospital, Headington, Oxford OX3 9DU, UK
+44 (0) 1865 222726 (fax 222717)
[log in to unmask] http://www.fmrib.ox.ac.uk/~steve
---------------------------------------------------------------------------





===================================

Please consider the environment before printing this e-mail

Cleveland Clinic is ranked one of the top hospitals
in America by U.S.News & World Report (2010).
Visit us online at http://www.clevelandclinic.org <http://www.clevelandclinic.org/> for
a complete listing of our services, staff and
locations.


Confidentiality Note: This message is intended for use
only by the individual or entity to which it is addressed
and may contain information that is privileged,
confidential, and exempt from disclosure under applicable
law. If the reader of this message is not the intended
recipient or the employee or agent responsible for
delivering the message to the intended recipient, you are
hereby notified that any dissemination, distribution or
copying of this communication is strictly prohibited. If
you have received this communication in error, please
contact the sender immediately and destroy the material in
its entirety, whether electronic or hard copy. Thank you.





---------------------------------------------------------------------------
Stephen M. Smith, Professor of Biomedical Engineering
Associate Director, Oxford University FMRIB Centre

FMRIB, JR Hospital, Headington, Oxford OX3 9DU, UK
+44 (0) 1865 222726 (fax 222717)
[log in to unmask] http://www.fmrib.ox.ac.uk/~steve
---------------------------------------------------------------------------





===================================

 Please consider the environment before printing this e-mail

Cleveland Clinic is ranked one of the top hospitals
in America by U.S.News & World Report (2010).
Visit us online at http://www.clevelandclinic.org for
a complete listing of our services, staff and
locations.


Confidentiality Note: This message is intended for use
only by the individual or entity to which it is addressed
and may contain information that is privileged,
confidential, and exempt from disclosure under applicable
law. If the reader of this message is not the intended
recipient or the employee or agent responsible for
delivering the message to the intended recipient, you are
hereby notified that any dissemination, distribution or
copying of this communication is strictly prohibited. If
you have received this communication in error, please
contact the sender immediately and destroy the material in
its entirety, whether electronic or hard copy. Thank you.

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager